Iron and iron-related parameters in oncology

Trace Elements and Electrolytes

Volumn 22, Issue 2, 2005, Pages 142-149

  Konemann S ^a   Boiling T ^a   Matzkies, F ^b   Willich, N ^a   Kisters, K ^c   Micke, O ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Nephrologic Praxis Clinic in the Medical Center   (Germany)

^c ST ANNA HOSPITAL   (Germany)

Author keywords

Anemia of chronic disease; Ferritin; Iron; Oncology; Transferrin

Indexed keywords

CYANOCOBALAMIN; CYTOCHROME; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; GAMMA INTERFERON; INTERLEUKIN 1; IRON; IRON DEXTRAN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANEMIA OF CHRONIC DISEASE; CANCER; CARCINOGENESIS; CELL METABOLISM; CELL TRANSPORT; CELL TYPE; CYTOKINE PRODUCTION; ELECTRON TRANSPORT; HUMAN; INFECTION; IRON BALANCE; IRON METABOLISM; MACROPHAGE; NONHUMAN; OXYGEN AFFINITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 18344378093     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep22142     Document Type: Review

References (53)

1. Alvarez-Hernandez X, Licega J, McKay IC, Brock JH 1989 Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61: 319-322
2. Argilés JM, Moore-Carrasco R, Fuster G, Busquets S, Löpez-Soriano FJ 2003 Cancer cachcxia: the molecular mechanisms. Int Biochem Cell Biol 35: 405-409
3. Auerbach M, Ballant H, Trout JR, Mcllwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J 2004 Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22: 1301-1307
4. Baumann-Kurer S, Seifert B, Michel B, Ruegg R, Fehr J 1995 Predicition of iron deficiency in chronic inflammatory disease anemia. Brit J Haematol 91: 820-826
5. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennet C, Engert A 2004 Erythropoietin for patients with malignant disease (Cochrane Review). The Cochrane Library, Issue 3, 2004. John Wiley and Sons, Chiehester, UK
6. Brittenham GM 1995 Disorders of iron metabolism: iron deficiency and overload. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds) Hematology - Basic Principles and Practice. Churchill Livingstone, New York, pp 492-523
7. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW 1996 Tumor oxygenation prediets for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 50: 941-943
8. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW 1997 Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-289
9. Brock JH, Alverez-Hernandez X 1989 Modulation of macrophage iron metabolism by tumor necrosis factor and interleukin 1. FEMS Microbiol Immunol 47: 309-310
10. Büntzel J, Bruns F, Micke O 2004 Report of the fourth Münster Workshop on Trace Elements and Electrolytes - AKTE 2/2002, Gelsenkirehen/Heme, Germany, November 23, 2002. Trace Elem Electrolytes 21: 130-131
11. Byrd TF, Horwitz MA 1993 Regulation of transferrin receptor expression and ferritin content in human mononuclear macrophages coordinate upregulation by iron transferrin and downregulation by interferon-γ. J Clin Invest 91: 969-976
12. Cengiz M, Gurkaynak M, Vural H, Aksoy N, Cengiz B, Yildiz F, Atahn IL 2003 Tissue trace element change after total body irradiation. Nephron Exp Nephrol 94: 12-16
13. Cildag O, Altinisik M, Kozaci D, Karadag F, Kiter G, Altun C 2004 Alterations in trace elements and oxidative stress in lung cancer. Trace Elem Electrolytes 21: 23-27
14. Conrad ME, Umbreit JN 2000 Iron absorption and transport - an update. Am J Hematol 64: 287-298
15. Cox PA 1989 The Elements: Their Origin, Abundance and Distribution. Oxford University Press, Oxford, UK
16. Dewhurst K 1966 Dr. Thomas Sydenham (1624-1689): His Life and Original Writings. University of California Press, Berkeley, CA, U SA
17. Donfrancesco A, Deb G, DeSio L, Cozza R, Castellano A 1996 Role of Deferoxamine in tumor therapy. Act Haematol 95: 66-69
18. Dunst J 2004 Erythropoietin and radiotherapy: a dangerous combination? Strahlenther Onkol 180: 133-135
19. Glaser CM, Millesi W, Kornek GV, Lang S, Schull B, Watzinger F, Selzer E, Lavey RS 2001 Impact of hemoglobin level and use of recombinant crythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50: 705-715
20. Goodnough LT 2002 Erythropoiesis, iron metabolism. In: Nowrousian MR (ed) Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Springer, Wien, pp 23-38
21. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portelance L, Crook J, Jones KD 1999 The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86: 1528-1536
22. Hart GD 2001 Description of blood and blood disorders before the advent of laboratory medicine. Br J Hematol 115: 719-728
23. Henke M, Guttenberger R 2000 Erthropoietin in radiation oncology - a review. Oncology 58: 175-182
24. Henke M, Laszig R, Rube C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H 2003 Erythropoictin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362: 1255-1260
25. Hoeckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P 1996 Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 50: 4509-4515
26. Hoppe-Seyler F 1864 Über die chemischen und optischen Eigenschaften des Blutfarbstoffs. Virehows Arch 29: 233-235
27. Itri LM 2002 Managing cancer-related anaemia with epoetin alfa. Nephrol Dial Transplant 17 (Suppl 1): 73-77
28. Ludwig H, Fritz E 1998 Anemia in cancer patients. Semin Oncol 25 (Suppl 7): 2-6
29. Manegold C 1998 The causes and prognostic significance of low hemoglobin levels in tumor patients. Strahlenther Onkol 174 (Suppl IV): 17-19
30. Matzkies FK, Hillebrand U, Kisters K, Micke O 2001 Combined crythropoietin and iron therapy in comparison to conventional crythropoietin and blood transfusion in patients with advanced carcinoma during radiation. Trace Elem Electrolytes 18: 96-97
31. Matzkies FK, Tokmak F, Rump LC, Micke O 2004 Eisen und Eisenparameter in der Tumortherapie. In: Büntzel J, Kisters K, Micke O, Mücke R (eds) Zytoprotcktion, Spurenelemente und Elektrolyte in der Tumortherapic. Dustri, Münchcn-Deiscnhofen, pp 150-156
32. McCord JM 1998 Iron, free radicals, and oxidative injury. Semin Hematol 55: 5-12
33. Micke O 2000 Quo vadis trace elements? History and future of trace elements in radiation oncology. Trace Elem Electrolytes 17: 187-189
34. Micke O, Matzkies F, Schäfer U, Kisters K, Hillebrand U, Willich N 2003 Erythropoictin and iron status in advanced cancer patients. Support Care Cancer 11: 426
35. Mosmann TR, Coffmann RL 1989 Th1 and Th2 cells: differential patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173
36. Nowrousian MR 2002a Classification and characterization of anemia in cancer. In: Nowrousian MR (ed) Recombinant Human Erythropoictin (rhEPO) in Clinical Oncology. Springer, Wien, pp 23-38
37. Nowrousian MR 2002b Pathophysiology of cancer-related anemia. In: Nowrousian MR (ed) Recombinant Human Erythropoietin (rhEPO) in clinical oncology. Springer, Wien, pp 39-62
38. Pais I, Jones JB 1997 The Handbook of Trace Elements. St. Lucie Press, Boca Raton, USA, pp 112-114
39. Perutz M 1995 Hoppe-Seyler, Stokes and haemoglobin. Biol Chem Hoppe Seyler 570: 449-450
40. Pollet S, Kisters K 2003 Trace elements and electrolytes - Selected abstracts of the 3rd International Symposium on Trace Elements in Humans: New perspectives 4-6 October 2001, Athens, Greece. Trace Elem Electrolytes 20: 69-78
41. Ponka P 1999 Cellular iron metabolism. Kidney int 55 (Suppl 69): 2-11
42. Ponka P Beaumont C, Richardson DR 1998 Function and regulation of transferrin and ferritin. Semin Hematol 55: 35-54
43. Poskitt EM 2003 Early history of iron deficiency. Br J Haematol 122: 554-562
44. Romagnani S 1997 The Th1/Th2 paradigm. Immunol Today 18: 263-266
45. Samuni Y, DeGraff W, Chevion M, Mitchell JB, Cook JA 2001 Radiation sensitization of mammalian cells by metal chelators. Radiation Research 155: 304-310
46. Seder RA, Paul WE 1994 Acquisition of lymphkinc producing phenotype by CD4+ cells. Ann Rev Immunol 12: 635-673
47. Schäfer U, Micke O, Müller SB, Schülter P, Willich N 2003 Hemoglobin as an indipendent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol 179: 527-534
48. Weinberg ED 1999 Iron therapy and cancer. Kidney Int 55 (Suppl 69): 131-134
49. Weiss G 1999 Iron and anemia of chronic disease. Kidney Int 55 (Suppl 69): 12-17
50. Weiss G 2002 Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16: 87-96
51. Weiss G, Bogdan C, Hentze MW 1997a Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines 1L-4, IL-13. J Immunol 158: 420-425
52. Weiss G, Houston T, Kastner S, Grünewald K, Brock J 1997b Regulation of cellular iron metabolism by crythropoictin: activation of iron regulatory protein and up-regulation of transferrin receptor in crythroid cells. Blood 89: 680-687
53. Wick M, Pinggera W, Lehmann P 2002 Klinik und Labor, Eisenstoffwechsel. Neue Konzepte bei renalen und Tumoranämien (7th ed). Springer, Wien